VivoSeq
Other

SLE

0

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

SLE is an early-stage landscape with 0 programs across 1 company. The most active players are EMD Serono Research & Development Institute, Inc..

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

EMD Serono Research & Development Institute, Inc. logo

EMD Serono Research & Development Institute, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

11

clinical trials

Completed5 · 45%
Unknown status2 · 18%
Recruiting2 · 18%
Active, not recruiting1 · 9%
Withdrawn1 · 9%

Clinical Trials

Trial Activity

11 trials

Safety of Administering Isoniazid to SLE Patients to Prevent TB
Recruiting·UUniversitas Padjadjaran·Phase 2/3·NCT06618573·60 enrolled
The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty
Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 4·NCT06283381·40 enrolled
Centrally Acting ACE Inhibition in SLE
Active, not recruiting·NNorthwell Health·Phase 2·NCT04486118·36 enrolled
Omental Islet Transplant
Completed·UUniversity of Alberta·Phase 1/2·NCT02821026·4 enrolled
Effect of Reparel Knee Sleeve With Knee Injection
Completed·UUniversity of Alabama at Birmingham·N/A·NCT04859764·40 enrolled
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Completed·EMD Serono Research & Development Institute, Inc. logoEMD Serono Research & Development Institute, Inc.·Phase 2·NCT05162586·456 enrolled
BLYS and IFN in SLE
Completed·UUniversity of Alabama at Birmingham·N/A·NCT00611611·39 enrolled
Aralast NP in Islet Transplant
Completed·UUniversity of Alberta·Phase 1/2·NCT02520076·5 enrolled
Levothyroxine in Pregnant SLE Patients
Withdrawn·JJohns Hopkins University·Phase 4·NCT01276782
Islet Transplant Alone in OMENtum
Unknown status·—·Phase 2·NCT02803905·12 enrolled
A Model About the Response of Belimumab in SLE
Unknown status·FFirst Affiliated Hospital Xi'an Jiaotong University·Phase 4·NCT04893161·72 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)